Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · HealthStream (HSTM)

HealthStream promotes Michael M. Collier to Chief Operating Officer and EVP

Neutral Impact 3 of 5 leadership Written later

HealthStream named Michael M. Collier its Chief Operating Officer and Executive Vice President, up from EVP of Corporate Strategy, Development & Operations, and he will lead enterprise operations including M&A and AI transformation. The filing also discloses option grants to Collier and CEO Robert A. Frist, Jr. of 18,781 shares each at $23.96, which equals the May 8, 2026 closing price. The promotion is a management change, and the option grants add to executive equity compensation.

Key points

  • Michael M. Collier promoted from EVP, Corporate Strategy, Development & Operations to Chief Operating Officer and EVP, announced alongside May 4, 2026 Q1 results release
  • Collier receives stock options for 18,781 shares at $23.96 per share, vesting 15%, 20%, 20%, 20% and 25% over five years
  • CEO Robert A. Frist, Jr. receives options for 18,781 shares at $23.96 per share on the same May 8, 2026 grant date and vesting schedule

The filing

CompanyHealthStream (HSTM)
Form8-K, current report
Filed with the SECMay 8, 2026, 5:19 PM ET
Accession number0001437749-26-015956

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 6:59 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 08, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.